Paysign Inc. (PAYS) PT Raised to $15 at DA Davidson

DA Davidson analyst Peter Heckmann raised the price target on Paysign Inc. (NASDAQ: PAYS) to $15.00 (from $12.00) while maintaining a Buy rating.

The analyst commented, "After digging further into the Patient Affordability niche and participating in a number of meetings with management over the past two months, we have become more confident that the company should continue to generate strong growth in the segment in the intermediate term. As a result, we have nudged our 2027 forecasts higher and introduced forecasts for 2028. We are maintaining our BUY rating on Paysign and raising our price target to $15 (from $12)."

You May Also Be Interested In

• HSBC Upgrades Target (TGT) to Buy
• Annexon Biosciences (ANNX) PT Raised to $15 at JPMorgan
• Freedom Capital Reiterates Buy Rating on CoreWeave (CRWV)